201 related articles for article (PubMed ID: 28834385)
1. Long-term results of deep sclerectomy in normal-tension glaucoma.
Harju M; Suominen S; Allinen P; Vesti E
Acta Ophthalmol; 2018 Mar; 96(2):154-160. PubMed ID: 28834385
[TBL] [Abstract][Full Text] [Related]
2. Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c.
Suominen S; Harju M; Kurvinen L; Vesti E
Acta Ophthalmol; 2014 Nov; 92(7):701-6. PubMed ID: 24373326
[TBL] [Abstract][Full Text] [Related]
3. The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results.
Suominen S; Harju M; Ihanamäki T; Vesti E
Acta Ophthalmol; 2010 Feb; 88(1):27-32. PubMed ID: 19775310
[TBL] [Abstract][Full Text] [Related]
4. Deep sclerectomy augmented with combination of absorbable biosynthetic sodium hyaluronate scleral implant and mitomycin C or with mitomycin C versus trabeculectomy: long-term results.
Mesci C; Erbil HH; Karakurt Y; Akçakaya AA
Clin Exp Ophthalmol; 2012; 40(4):e197-207. PubMed ID: 21668789
[TBL] [Abstract][Full Text] [Related]
5. Deep sclerectomy with mitomycin C for glaucoma secondary to uveitis.
Anand N
Eur J Ophthalmol; 2011; 21(6):708-14. PubMed ID: 21445837
[TBL] [Abstract][Full Text] [Related]
6. Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
Ollikainen ML; Puustjärvi TJ; Rekonen PK; Uusitalo HM; Teräsvirta ME
Acta Ophthalmol; 2011 Sep; 89(6):548-55. PubMed ID: 19925527
[TBL] [Abstract][Full Text] [Related]
7. Deep Sclerectomy With Mitomycin C and Injectable Cross-linked Hyaluronic Acid Implant: Long-term Results.
Bettin P; Di Matteo F; Rabiolo A; Fiori M; Ciampi C; Bandello F
J Glaucoma; 2016 Jun; 25(6):e625-9. PubMed ID: 26372149
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of deep sclerectomy in childhood glaucoma in Saudi Arabia.
Al-Obeidan SA; Osman Eel-D; Dewedar AS; Kestelyn P; Mousa A
Acta Ophthalmol; 2014 Feb; 92(1):65-70. PubMed ID: 23241279
[TBL] [Abstract][Full Text] [Related]
9. Non-penetrating glaucoma surgery augmented with mitomycin C or 5-fluorouracil in eyes at high risk of failure of filtration surgery: long-term results.
Choudhary A; Wishart PK
Clin Exp Ophthalmol; 2007; 35(4):340-7. PubMed ID: 17539786
[TBL] [Abstract][Full Text] [Related]
10. Nonpenetrating deep sclerectomy with the use of adjunctive mitomycin C.
Neudorfer M; Sadetzki S; Anisimova S; Geyer O
Ophthalmic Surg Lasers Imaging; 2004; 35(1):6-12. PubMed ID: 14750756
[TBL] [Abstract][Full Text] [Related]
11. Deep sclerectomy with mitomycin C in failed trabeculectomy.
Rebolleda G; Muñoz-Negrete FJ
Eye (Lond); 2007 Jan; 21(1):23-8. PubMed ID: 16311522
[TBL] [Abstract][Full Text] [Related]
12. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma.
Kozobolis VP; Christodoulakis EV; Tzanakis N; Zacharopoulos I; Pallikaris IG
J Glaucoma; 2002 Aug; 11(4):287-93. PubMed ID: 12169964
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
Jayaram H; Scawn R; Pooley F; Chiang M; Bunce C; Strouthidis NG; Khaw PT; Papadopoulos M
Ophthalmology; 2015 Nov; 122(11):2216-22. PubMed ID: 26315044
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of CO
Cutolo CA; Bagnis A; Scotto R; Bonzano C; Traverso CE
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):181-186. PubMed ID: 29147757
[TBL] [Abstract][Full Text] [Related]
15. Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C.
Cillino S; Di Pace F; Casuccio A; Lodato G
Ophthalmologica; 2005; 219(5):281-6. PubMed ID: 16123554
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study).
Mostafaei A; Taheri N; Ghojazadeh M; Latifi A; Moghaddam N
Int Ophthalmol; 2019 Oct; 39(10):2341-2351. PubMed ID: 30656509
[TBL] [Abstract][Full Text] [Related]
17. Deep sclerectomy augmented with mitomycin C.
Anand N; Atherley C
Eye (Lond); 2005 Apr; 19(4):442-50. PubMed ID: 15746961
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma.
Sihota R; Angmo D; Chandra A; Gupta V; Sharma A; Pandey RM
Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):1153-9. PubMed ID: 25940554
[TBL] [Abstract][Full Text] [Related]
19. Combined ab externo and ab interno revision of failed filtering blebs with adjunctive mitomycin C.
Magacho L; Shetty RK
Eur J Ophthalmol; 2014; 24(2):196-201. PubMed ID: 23934826
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study.
Ollikainen M; Puustjärvi T; Rekonen P; Uusitalo H; Teräsvirta M
Acta Ophthalmol; 2010 Feb; 88(1):20-6. PubMed ID: 19432842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
